EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beta‐Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS‐Mediated Lipid Metabolic Reprogramming

Xiaonan Huang, Zhen Hu, Weilong Shang, Juan Chen, Qiwen Hu, Yumin Zhou, Ruolan Ding, Jing Yin, Mengyang Li, He Liu, Jianxiong Dou, Huagang Peng und 9 weitere

Journal of Extracellular Vesicles · 2025-05 · 14 (5)

DOI: 10.1002/jev2.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 02.05.2025. Verfasst von Xiaonan Huang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, College of Basic Medical Sciences, Key Laboratory of Microbial Engineering under the Educational Committee in Chongqing, …. Hauptthemen laut MEDLINE: Staphylococcus aureus, Extracellular Vesicles, Reactive Oxygen Species, Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial extracellular vesicles (EVs) are natural reservoirs of biological active substances. They exhibit promising application in developing bioproducts such as vaccine, drug‐delivery system and anticancer agent. However, the low yield of naturally secreted EVs during bacterial growth is a bottleneck factor that restricts EV applications. In this study, we showed that sub‐minimum inhibitory concentration (MIC) of β‐lactams boosted EV production in various Staphylococcus aureus strains. The expression of penicillin‐binding protein (PBP) genes increased after β‐lactam treatment, and the inactivation of alternative PBPs promoted EV secretion of S. aureus . We also demonstrated that sub‐MIC β‐lactams promoted EV production via a reactive oxygen species (ROS)‐dependent pathway. Deletion of redundant pbp genes enhanced oxacillin (OXA)‐stimulated ROS levels. Transcriptomic and lipidomic analyses revealed that OXA‐induced ROS triggered lipid metabolic reprogramming in S. aureus . Particularly, ROS promoted lipid peroxidation (LPO) and increased the biosynthesis of phosphatidic acid (PA) and lipoteichoic acid (LTA) that contributed to EV generation. Furthermore, OXA treatment altered the diversity of EV‐loaded proteins. OXA‐treated ∆ agr /OXA EVs induced stronger Dengue EDIII‐specific antibodies in BALB/c mice than did ∆ agr EVs. Overall, this study provided mechanic insights into β‐lactam‐promoted EV production in S. aureus , and highlighted the potential strategies to prepare EVs for various applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusExtracellular VesiclesReactive Oxygen SpeciesAnti-Bacterial Agentsbeta-LactamsLipid MetabolismAnimalsMiceStaphylococcal InfectionsMicrobial Sensitivity TestsMice, Inbred BALB COxacillinbeta Lactam AntibioticsMetabolic Reprogramming

Stichwörter der Autor:innen

Staphylococcus aureusextracellular vesiclelipid metabolismpenicillin binding proteinsreactive oxygen speciesβ‐lactam antibiotics

Substanzen

Reactive Oxygen SpeciesAnti-Bacterial Agentsbeta-LactamsOxacillinbeta Lactam Antibiotics

Autor:innen und Institutionen

  • Department of Microbiology, College of Basic Medical Sciences, Key Laboratory of Microbial Engineering under the Educational Committee in Chongqing, Army Medical University, Chongqing, China.
  • Department of Pharmacy, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing, China.
  • Department of Microbiology, School of Medicine, Chongqing University, Chongqing, China.
  • Department of Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Emergency Medicine, Xinqiao Hospital, Army Medical University, Chongqing, China.

ORCID-Profile: Xiancai Rao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, X., Hu, Z., Shang, W., Chen, J., Hu, Q., Zhou, Y., Ding, R., Yin, J., Li, M., Liu, H., Dou, J., Peng, H., Rao, Y., Liu, L., Wang, Y., Tan, L., Yang, Y., Wu, J., Xiao, C., …, & Rao, X. (2025). Beta‐Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS‐Mediated Lipid Metabolic Reprogramming. Journal of Extracellular Vesicles, 14(5). https://doi.org/10.1002/jev2.70077

Vancouver

Huang X, Hu Z, Shang W, Chen J, Hu Q, Zhou Y, et al. Beta‐Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS‐Mediated Lipid Metabolic Reprogramming. Journal of Extracellular Vesicles. 2025;14(5). doi:10.1002/jev2.70077

BibTeX
@article{Huang2025,
  author = {Huang, Xiaonan and Hu, Zhen and Shang, Weilong and Chen, Juan and Hu, Qiwen and Zhou, Yumin and Ding, Ruolan and Yin, Jing and Li, Mengyang and Liu, He and Dou, Jianxiong and Peng, Huagang and Rao, Yifan and Liu, Lu and Wang, Yuting and Tan, Li and Yang, Yuhua and Wu, Jianghong and Xiao, Chuan and Yang, Yi and Rao, Xiancai},
  title = {Beta‐Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS‐Mediated Lipid Metabolic Reprogramming},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  volume = {14},
  number = {5},
  doi = {10.1002/jev2.70077}
}
Kostenlos starten →